Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
42
REGN Quote, Financials, Valuation and Earnings
Last price:
$550.01
Seasonality move
:
8.22%
Day range:
$546.57 - $558.35
52-week range:
$476.49 - $1,211.20
Dividend yield:
0.32%
P/E ratio:
13.95x
P/S ratio:
4.44x
P/B ratio:
2.01x
Volume:
1.1M
Avg. volume:
1.1M
1-year change:
-49.96%
Market cap:
$59.2B
Revenue:
$14.2B
EPS (TTM):
$39.28
Earnings Data
Next earnings date for REGN
Aug 01
2025
Most recent earnings per share
$7.27
Missed by $1.21
(Apr 29/2025)
Consensus Estimate
$8.48
(Apr 29/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
REGN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $3.5B | -- | -- | $9.39 | -- |
| 08/01/2025 | Q2 | $3.3B | -- | -- | $8.55 | -- |
| 04/29/2025 | Q1 | $3.2B | $3B | $7.27 | $8.48 | -$1.21 |
| 02/04/2025 | Q4 | $3.7B | $3.8B | $8.06 | $11.19 | -$3.13 |
| 10/31/2024 | Q3 | $3.7B | $3.7B | $11.54 | $11.70 | -$0.16 |
| 08/01/2024 | Q2 | $3.4B | $3.5B | $12.41 | $10.62 | $1.79 |
| 05/02/2024 | Q1 | $3.2B | $3.1B | $6.27 | $10.10 | -$3.83 |
| 02/02/2024 | Q4 | $3.3B | $3.4B | $10.19 | $10.75 | -$0.56 |
| 11/02/2023 | Q3 | -- | -- | $8.89 | $10.78 | -$1.89 |
| 08/03/2023 | Q2 | -- | -- | $8.50 | $9.90 | -$1.40 |
| 05/04/2023 | Q1 | -- | -- | $7.17 | $9.56 | -$2.39 |
| 02/03/2023 | Q4 | -- | -- | $10.50 | $10.01 | $0.49 |
| 11/03/2022 | Q3 | -- | -- | $11.66 | $9.48 | $2.18 |
| 08/03/2022 | Q2 | -- | -- | $7.47 | $8.76 | -$1.29 |
| 05/04/2022 | Q1 | -- | -- | $8.61 | $9.80 | -$1.19 |
| 02/04/2022 | Q4 | -- | -- | $19.69 | $20.30 | -$0.61 |
| 11/04/2021 | Q3 | -- | -- | $14.33 | $9.94 | $4.39 |
| 08/05/2021 | Q2 | -- | -- | $27.97 | $17.71 | $10.26 |
| 05/06/2021 | Q1 | -- | -- | $10.09 | $8.68 | $1.41 |
| 02/05/2021 | Q4 | -- | -- | $10.24 | $8.29 | $1.95 |
| 11/05/2020 | Q3 | -- | -- | $7.39 | $6.99 | $0.40 |
| 08/05/2020 | Q2 | -- | -- | $7.61 | $5.97 | $1.64 |
| 05/05/2020 | Q1 | -- | -- | $5.43 | $6.09 | -$0.66 |
| 02/06/2020 | Q4 | -- | -- | $6.93 | $7.17 | -$0.24 |
| 11/05/2019 | Q3 | -- | -- | $5.86 | $6.40 | -$0.54 |
| 08/06/2019 | Q2 | -- | -- | $6.02 | $5.42 | $0.60 |
| 05/07/2019 | Q1 | -- | -- | $4.45 | $5.52 | -$1.07 |
| 02/06/2019 | Q4 | -- | -- | $6.84 | $5.60 | $1.24 |
| 11/06/2018 | Q3 | -- | -- | $5.87 | $5.06 | $0.81 |
| 08/02/2018 | Q2 | -- | -- | $5.45 | $4.68 | $0.77 |
| 05/03/2018 | Q1 | -- | -- | $4.67 | $4.34 | $0.33 |
| 02/08/2018 | Q4 | -- | -- | $5.23 | $4.57 | $0.66 |
| 11/08/2017 | Q3 | -- | -- | $3.99 | $3.82 | $0.17 |
| 08/03/2017 | Q2 | -- | -- | $4.17 | $3.18 | $0.99 |
| 05/04/2017 | Q1 | -- | -- | $2.92 | $3.07 | -$0.15 |
| 02/09/2017 | Q4 | -- | -- | $3.04 | $3.05 | -$0.01 |
| 11/04/2016 | Q3 | -- | -- | $2.41 | $2.27 | $0.14 |
| 08/04/2016 | Q2 | -- | -- | $2.11 | $1.73 | $0.38 |
| 05/05/2016 | Q1 | -- | -- | $1.45 | $1.24 | $0.21 |
| 02/09/2016 | Q4 | -- | -- | $1.46 | $2.69 | -$1.23 |
| 11/04/2015 | Q3 | -- | -- | $2.59 | $2.62 | -$0.03 |
Regeneron Pharmaceuticals Earnings Questions
-
How Much did Regeneron Pharmaceuticals Generate in Revenue Last Quarter?
Regeneron Pharmaceuticals reported $3B worth of top line sales in its most recent quarter.
-
Did Regeneron Pharmaceuticals Beat Earnings Last Quarter?
Regeneron Pharmaceuticals announced earnings per share of $7.27 which represents a miss of analyst forecast a $8.48 per share.
-
Is Regeneron Pharmaceuticals Profitable?
Regeneron Pharmaceuticals reported $2.6B that represents $23.06 per share over the last quarter.
-
What is the Analyst Consensus for Regeneron Pharmaceuticals EPS Next Year?
Regeneron Pharmaceuticals's earnings are forecast to decrease from $38.34 per share to $44.92 per share next year representing a decrease of -6.65%.
-
When is Regeneron Pharmaceuticals's Earnings Date?
Regeneron Pharmaceuticals's next earnings date is August 1, 2025.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
